Study of Regorafenib for Urothelial Cancer Following Chemotherapy (UAB 1477)

Clinical trial NCT02459119 · COMPLETED

Trial details

NCT number: NCT02459119
Sponsor: University of Alabama at Birmingham
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Urothelial Cancer (Urinary Bladder, Ureters, or Renal Pelvis Cancer)

Start date: 2015-05-01
Primary completion: 2019-02-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.